Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock
CNBC
Looking beyond AI for the next big winner? This drug stock could be headed for a $2 trillion valuation.
Summary from CNBC
Read the full story on CNBCRelated stories
More business
See all →CNBC
Trump Administration Unlawfully Fired Maurene Comey, Judge Rules
CNBC
Meta announces $95 billion stock offering to fund AI expansion
CNBC
The arc of Trump: How the president lost the coalition that put him in the White House
NPR
What to Know About Brazil’s Election as Bolsonaro Faces Off With Lula
CNBC
Justice Department sues to block Alaska Senate race results if Republican loses
Ars Technica
Elon Musk's Starlink and Starshield, and what they mean to Ukraine
Top stories in the United States
See all →NBC News
Anthropic files for IPO as it competes for AI dominance
The Hollywood Reporter
Walter Koenig, actor who played Chekov on "Star Trek," dies at 90
CNBC
Microsoft offers buyouts to 60,000 employees
The Hollywood Reporter
Eric Bauza, actor who voiced Bugs Bunny and Daffy Duck, dies at 46
The Hollywood Reporter
Instagram Is Testing Ability to Share Videos up to 90 Minutes Long and Launches on Apple TV — but Unlike YouTube, It’s Still Not Going to Pay Creators
Yahoo Sports